Products & Services · Total Revenue
SPINRAZA — Total Revenue
Biogen SPINRAZA — Total Revenue increased by 5.0% to $374.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.8%, from $423.90M to $374.00M. Over 4 years (FY 2021 to FY 2025), SPINRAZA — Total Revenue shows a downward trend with a -5.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption or higher pricing power, while a decrease suggests competitive pressure or loss of market share.
Detailed definition
Represents the total gross revenue generated from the sale of a specific pharmaceutical product or therapeutic segment....
Peer comparison
Standard revenue reporting for specific drug franchises across major pharmaceutical companies.
Metric ID:
biib_segment_spinraza_total_revenueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $499.70M | $444.10M | $440.80M | $472.50M | $431.10M | $431.10M | $458.80M | $443.30M | $437.10M | $448.20M | $412.60M | $341.30M | $429.10M | $381.40M | $421.40M | $423.90M | $392.70M | $374.00M | $356.20M | $374.00M |
| QoQ Change | — | -11.1% | -0.7% | +7.2% | -8.8% | +0.0% | +6.4% | -3.4% | -1.4% | +2.5% | -7.9% | -17.3% | +25.7% | -11.1% | +10.5% | +0.6% | -7.4% | -4.8% | -4.8% | +5.0% |
| YoY Change | — | — | — | — | -13.7% | -2.9% | +4.1% | -6.2% | +1.4% | +4.0% | -10.1% | -23.0% | -1.8% | -14.9% | +2.1% | +24.2% | -8.5% | -1.9% | -15.5% | -11.8% |
Range$341.30M – $499.70M
CAGR-5.9%
Avg YoY Growth-4.7%
Median YoY Growth-4.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's spinraza — total revenue?
- Biogen (BIIB) reported spinraza — total revenue of $374.00M in Q1 2026.
- How has Biogen's spinraza — total revenue changed year-over-year?
- Biogen's spinraza — total revenue decreased by 11.8% year-over-year, from $423.90M to $374.00M.
- What is the long-term trend for Biogen's spinraza — total revenue?
- Over 4 years (2021 to 2025), Biogen's spinraza — total revenue has grown at a -5.1% compound annual growth rate (CAGR), from $1.91B to $1.55B.
- What does spinraza — total revenue mean?
- The total sales revenue earned from a specific product line.